Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO

NEXT STORY
Global Cell & Gene Therapy Sector on Pace for Annual Records in Product Approvals and Financings, Says Alliance for Regenerative Medicine
PREV STORY
DLH Awarded Contract for CDC NCHHSTP DHP Data Management Services
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mateon Therapeutics Team Publishes a New Peer-Reviewed Oncology Article on the Positive Clinical Study Results for Its Lead Anti-Leukemia Drug Combretastatin A1 Plus Cytarabine in Adult Patients With Relapsed Acute Myeloid Leukemia

author_avatar
NASDAQ Market News

Former Snapchat Executive Jason Halbert Addresses Hair Loss with Launch of Men’s Telehealth Platform Apollo Health Products

author_avatar
NASDAQ Market News

HOOKIPA advances HB-200 program to Phase 2 and prioritizes oncology portfolio based on clinical data updates across its novel arenaviral platform

author_avatar
NASDAQ Market News